Free Trial
NASDAQ:PETV

PetVivo (PETV) Stock Price, News & Analysis

PetVivo logo
$0.63 +0.04 (+7.17%)
As of 04/2/2025 03:43 PM Eastern

About PetVivo Stock (NASDAQ:PETV)

Key Stats

Today's Range
$0.55
$0.63
50-Day Range
$0.49
$0.80
52-Week Range
$0.29
$1.25
Volume
4,011 shs
Average Volume
23,156 shs
Market Capitalization
$15.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Remove Ads
Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Stock News Headlines

PetVivo closes Series B Convertible Preferred Stock offering
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.
Analyzing Apyx Medical (NASDAQ:APYX) & PetVivo (NASDAQ:PETV)
See More Headlines

PETV Stock Analysis - Frequently Asked Questions

PetVivo's stock was trading at $0.62 on January 1st, 2025. Since then, PETV shares have increased by 1.9% and is now trading at $0.6320.
View the best growth stocks for 2025 here
.

PetVivo Holdings, Inc. (NASDAQ:PETV) released its earnings results on Thursday, June, 29th. The company reported ($0.21) earnings per share for the quarter, meeting the consensus estimate of ($0.21). The company earned $0.13 million during the quarter. PetVivo had a negative net margin of 902.82% and a negative trailing twelve-month return on equity of 4,813.07%.

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

Last Earnings
6/29/2023
Today
4/02/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PETV
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,950,000.00
Net Margins
-902.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.05 million
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-21.07

Miscellaneous

Free Float
19,057,000
Market Cap
$14.89 million
Optionable
Not Optionable
Beta
2.38
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:PETV) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners